|
SE9501384D0
(sv)
|
1995-04-13 |
1995-04-13 |
Astra Ab |
Process for the preparation of respirable particles
|
|
SE9701956D0
(sv)
|
1997-05-23 |
1997-05-23 |
Astra Ab |
New composition of matter
|
|
CA2295076A1
(en)
*
|
1997-06-27 |
1999-01-07 |
Astra Aktiebolag |
New combination of antiasthma medicaments
|
|
SE9704186D0
(sv)
*
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
GB9806477D0
(en)
*
|
1998-03-26 |
1998-05-27 |
Glaxo Group Ltd |
Improved crystals
|
|
GB2341120B
(en)
|
1998-09-04 |
2002-04-17 |
Aea Technology Plc |
Controlling uniformity of crystalline precipitates
|
|
SE9803770D0
(sv)
*
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Dry powder pharmaceutical formulation
|
|
SE9804001D0
(sv)
*
|
1998-11-23 |
1998-11-23 |
Astra Ab |
New process
|
|
GB9826284D0
(en)
*
|
1998-12-01 |
1999-01-20 |
Rhone Poulence Rorer Limited |
Process
|
|
GB9826286D0
(en)
*
|
1998-12-01 |
1999-01-20 |
Rhone Poulence Rorer Limited |
Process
|
|
GB9828721D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Glaxo Group Ltd |
Novel apparatus and process
|
|
GB9905512D0
(en)
*
|
1999-03-10 |
1999-05-05 |
Smithkline Beecham Plc |
Process
|
|
GB9919693D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Rhone Poulenc Rorer Ltd |
Process
|
|
CZ20011726A3
(cs)
|
2000-05-26 |
2002-02-13 |
Pfizer Products Inc. |
Způsob reakční krystalizace, který umoľňuje řídit velikost částic
|
|
GB0015981D0
(en)
*
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0016040D0
(en)
*
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0016002D0
(en)
*
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US7037528B2
(en)
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
US6960256B2
(en)
|
2001-05-05 |
2005-11-01 |
Accentus Plc |
Formation of small crystals
|
|
DE10137017A1
(de)
*
|
2001-07-30 |
2003-02-20 |
Basf Ag |
Kristallisationsverfahren zur Einstellung kleiner Partikel
|
|
ATE336231T1
(de)
*
|
2001-08-29 |
2006-09-15 |
Dow Global Technologies Inc |
Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
EP1429749A2
(en)
*
|
2001-09-26 |
2004-06-23 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
US7931022B2
(en)
*
|
2001-10-19 |
2011-04-26 |
Respirks, Inc. |
Method and apparatus for dispensing inhalator medicament
|
|
US20030191151A1
(en)
*
|
2001-10-26 |
2003-10-09 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
|
US6702997B2
(en)
|
2001-10-26 |
2004-03-09 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
|
US20030203930A1
(en)
*
|
2001-10-26 |
2003-10-30 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
|
US20030140920A1
(en)
*
|
2001-10-26 |
2003-07-31 |
Dey L.P. |
Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
|
|
JP2003221335A
(ja)
|
2001-10-26 |
2003-08-05 |
Dey Lp |
慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
|
|
US8541399B2
(en)
|
2002-02-19 |
2013-09-24 |
Resolution Chemicals Limited |
Solvent-based sterilisation of pharmaceuticals
|
|
DE10214031A1
(de)
*
|
2002-03-27 |
2004-02-19 |
Pharmatech Gmbh |
Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
|
|
FI20020857A7
(fi)
*
|
2002-05-07 |
2003-11-08 |
Focus Inhalation Oy |
Amorfisen aineen muuntaminen vastaavaksi kiteiseksi aineeksi spraykuivaamalla ja käyttämällä kiteistä spraykuivattua ainetta lääkevalmisteissa
|
|
WO2004002551A2
(en)
*
|
2002-06-28 |
2004-01-08 |
Advanced Inhalation Research, Inc. |
Inhalable epinephrine
|
|
GB0216700D0
(en)
|
2002-07-18 |
2002-08-28 |
Astrazeneca Ab |
Process
|
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
|
US20040028746A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Sonke Svenson |
Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
|
|
US20040028747A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Tucker Christopher J. |
Crystalline drug particles prepared using a controlled precipitation process
|
|
KR20050056222A
(ko)
*
|
2002-09-30 |
2005-06-14 |
아쿠스피어 인코포레이티드 |
흡입용 지속 방출형 다공성 미세입자
|
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
|
US20040121003A1
(en)
*
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
|
US6962006B2
(en)
*
|
2002-12-19 |
2005-11-08 |
Acusphere, Inc. |
Methods and apparatus for making particles using spray dryer and in-line jet mill
|
|
WO2004066912A2
(en)
*
|
2003-01-31 |
2004-08-12 |
Technion Research & Development Foundation Ltd. |
Anti-inflammatory compositions and uses thereof
|
|
GB0302673D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
|
SI1610878T1
(sl)
*
|
2003-02-21 |
2015-02-27 |
University Of Bath |
Postopek za proizvodnjo delcev
|
|
US7041144B2
(en)
*
|
2003-03-04 |
2006-05-09 |
Five Star Technologies, Inc. |
Hydrodynamic cavitation crystallization process
|
|
US7511079B2
(en)
*
|
2003-03-24 |
2009-03-31 |
Baxter International Inc. |
Methods and apparatuses for the comminution and stabilization of small particles
|
|
US20060182808A1
(en)
*
|
2003-04-29 |
2006-08-17 |
Akzo Nobel N.V. |
Antisolvent solidification process
|
|
WO2004110585A1
(ja)
*
|
2003-06-10 |
2004-12-23 |
Taisho Pharmaceutical Co., Ltd. |
放射球状晶析物およびその製造方法並びにこれを利用するドライパウダー製剤
|
|
SE0302029D0
(sv)
*
|
2003-07-07 |
2003-07-07 |
Astrazeneca Ab |
Novel process
|
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
|
US20050196416A1
(en)
*
|
2004-02-05 |
2005-09-08 |
Kipp James E. |
Dispersions prepared by use of self-stabilizing agents
|
|
TWI341836B
(en)
|
2004-03-11 |
2011-05-11 |
Theravance Inc |
Biphenyl compounds useful as muscarinic receptor antagonists
|
|
WO2005105065A2
(en)
*
|
2004-05-05 |
2005-11-10 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors for treating inflammatory bowel diseases
|
|
US7498445B2
(en)
*
|
2004-05-05 |
2009-03-03 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof
|
|
US7968575B2
(en)
*
|
2004-05-05 |
2011-06-28 |
Renopharm Ltd. |
Nitric oxide donors and uses thereof
|
|
WO2005105278A2
(en)
*
|
2004-05-05 |
2005-11-10 |
Akzo Nobel N.V. |
Antisolvent emulsion solidification process
|
|
US8134010B2
(en)
*
|
2004-05-05 |
2012-03-13 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
|
|
US20060009435A1
(en)
*
|
2004-06-23 |
2006-01-12 |
Joseph Kaspi |
Synthesis and powder preparation of fluticasone propionate
|
|
WO2006023460A2
(en)
|
2004-08-16 |
2006-03-02 |
Theravance, Inc. |
COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
|
|
WO2006045795A2
(en)
*
|
2004-10-29 |
2006-05-04 |
Akzo Nobel N.V. |
Processes involving the use of antisolvent crystallization
|
|
US20060120972A1
(en)
*
|
2004-11-09 |
2006-06-08 |
Peter Engels |
9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
|
|
DE102005011786A1
(de)
|
2005-03-11 |
2006-09-14 |
Pharmasol Gmbh |
Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
|
|
US20090186088A1
(en)
*
|
2005-03-18 |
2009-07-23 |
Nanomaterials Technology Pte Ltd |
Inhalable drug
|
|
EP1868577A4
(en)
|
2005-04-15 |
2009-12-09 |
Reddys Lab Inc Dr |
Lacidipine PARTICLE
|
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
|
AU2006269961B2
(en)
*
|
2005-07-15 |
2012-07-19 |
Map Pharmaceuticals, Inc. |
Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
|
|
WO2007009164A1
(en)
*
|
2005-07-15 |
2007-01-25 |
Eiffel Technologies Limited |
Method of particle formation
|
|
US20070026073A1
(en)
*
|
2005-07-28 |
2007-02-01 |
Doney John A |
Amorphous efavirenz and the production thereof
|
|
US20070099883A1
(en)
*
|
2005-10-07 |
2007-05-03 |
Cheryl Lynn Calis |
Anhydrous mometasone furoate formulation
|
|
EP1954245A2
(en)
*
|
2005-11-15 |
2008-08-13 |
Baxter International Inc. |
Compositions of lipoxygenase inhibitors
|
|
EP1973523A2
(en)
*
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
US20070148211A1
(en)
*
|
2005-12-15 |
2007-06-28 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for oral administration
|
|
US7913223B2
(en)
*
|
2005-12-16 |
2011-03-22 |
Dialogic Corporation |
Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
|
|
US20080085315A1
(en)
*
|
2006-10-10 |
2008-04-10 |
John Alfred Doney |
Amorphous ezetimibe and the production thereof
|
|
WO2008057048A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Nanomaterials Technology Pte Ltd |
Nano & micro-sized particles of statin compounds and process for forming same
|
|
WO2008076780A2
(en)
*
|
2006-12-14 |
2008-06-26 |
Isp Investments Inc. |
Amorphous valsartan and the production thereof
|
|
WO2008080037A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Isp Investments Inc. |
Carotenoids of enhanced bioavailability
|
|
WO2008080047A2
(en)
*
|
2006-12-23 |
2008-07-03 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
|
US20080181961A1
(en)
*
|
2007-01-26 |
2008-07-31 |
Isp Investments, Inc. |
Amorphous oxcarbazepine and the production thereof
|
|
JP5508859B2
(ja)
*
|
2007-01-26 |
2014-06-04 |
アイエスピー インヴェストメンツ インコーポレイテッド |
噴霧乾燥製品を製造するための調剤処理方法
|
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
|
US8426467B2
(en)
*
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
US8722736B2
(en)
*
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
EP2191821A1
(en)
*
|
2008-11-26 |
2010-06-02 |
CHIESI FARMACEUTICI S.p.A. |
Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation
|
|
CN102405044A
(zh)
|
2009-02-06 |
2012-04-04 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
|
US20100291221A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Robert Owen Cook |
Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
|
|
US20100294986A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Massachusetts Institute Of Technology |
Supercritical fluid facilitated particle formation in microfluidic systems
|
|
US20100298602A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Massachusetts Institute Of Technology |
Systems and methods for microfluidic crystallization
|
|
HUE026414T2
(hu)
|
2009-07-15 |
2016-05-30 |
Theravance Biopharma R&D Ip Llc |
Bifenil-vegyület kristályos szabad-bázis formája
|
|
EP2477642A4
(en)
*
|
2009-09-17 |
2013-03-13 |
Mutual Pharmaceutical Co |
METHOD FOR THE TREATMENT OF ASTHMA WITH ANTIVIRUS AGENTS
|
|
HRP20181266T1
(hr)
*
|
2009-10-01 |
2018-10-05 |
Adare Pharmaceuticals, Inc. |
Kortikosteroidni pripravci za oralnu primjenu
|
|
US9889098B2
(en)
|
2009-10-22 |
2018-02-13 |
Vizuri Health Sciences Llc |
Methods of making and using compositions comprising flavonoids
|
|
EP2542082B8
(en)
|
2010-03-03 |
2020-06-17 |
Neonc Technologies Inc. |
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-perillyl alcohol
|
|
CN101849910B
(zh)
*
|
2010-05-18 |
2012-02-22 |
重庆华邦制药股份有限公司 |
一种二丙酸倍他米松微粒的制备方法
|
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
|
EP2883543B1
(en)
|
2010-08-27 |
2016-11-16 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising perillyl alcohol carbamates
|
|
CA2812263A1
(en)
|
2010-09-22 |
2012-03-29 |
Map Pharmaceuticals, Inc. |
Corticosteroid particles and method of production
|
|
EP3130579B1
(en)
|
2010-12-17 |
2024-02-07 |
University of Southern California |
Conjugates of isoperillyl alcohol
|
|
CN102134236B
(zh)
*
|
2011-04-15 |
2013-07-24 |
北方民族大学 |
微细克拉霉素粉体的制备方法
|
|
CN103649104A
(zh)
*
|
2011-07-08 |
2014-03-19 |
辉瑞股份有限公司 |
用于制备氟替卡松丙酸酯形式1的方法
|
|
BR112014008114B1
(pt)
|
2011-10-11 |
2022-07-26 |
Chiesi Farmaceutici S.P.A. |
Micropartículas cristalinas, formulação farmacêutica, inalador dosimetrado pressurizado, formulação farmacêutica, processo para preparar microparticulas cristalinas e uso de micropartículas cristalinas
|
|
DE102012221219B4
(de)
*
|
2012-11-20 |
2014-05-28 |
Jesalis Pharma Gmbh |
Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
|
|
PL2968312T3
(pl)
|
2013-03-15 |
2018-08-31 |
Verona Pharma Plc |
Kombinacja leków
|
|
WO2015034678A2
(en)
|
2013-09-06 |
2015-03-12 |
Aptalis Pharmatech, Inc. |
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
|
|
EP3231444B1
(en)
|
2014-05-12 |
2019-12-18 |
Verona Pharma PLC |
New treatment
|
|
JP6530480B2
(ja)
*
|
2014-07-08 |
2019-06-12 |
アムファスター ファーマシューティカルズ，インコーポレイティド |
微小インスリン、微小インスリン類似体及びそれらの製造方法
|
|
EP3261441B1
(en)
|
2015-02-12 |
2020-09-09 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising perillyl alcohol derivatives
|
|
US10322168B2
(en)
|
2016-01-07 |
2019-06-18 |
Amphastar Pharmaceuticals, Inc. |
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
|
|
TWI777515B
(zh)
|
2016-08-18 |
2022-09-11 |
美商愛戴爾製藥股份有限公司 |
治療嗜伊紅性食道炎之方法
|
|
DK3547836T3
(da)
|
2016-11-30 |
2024-11-18 |
Univ Southern California |
Perillylalkohol-3 brompyruvat-konjugat og fremgangsmåder til behandling af cancer
|
|
EP3749291B1
(en)
|
2018-02-08 |
2024-01-03 |
University of Southern California |
Methods of permeabilizing the blood brain barrier
|
|
WO2020205539A1
(en)
|
2019-03-29 |
2020-10-08 |
Vizuri Health Sciences Consumer Healthcare, Inc. |
Compositions and methods for the prevention and treatment of radiation dermatitis, eczema, burns, wounds and certain cancers
|
|
CN114262316A
(zh)
*
|
2021-12-24 |
2022-04-01 |
嘉应学院 |
纳米橙皮素、其制备方法及所用双匀浆空化射流系统
|